References
- Bae GS, Seo SW, Kim MS, et al. (2011). The roots of Nardostachys jatamansi inhibits lipopolysaccharide-induced endotoxin shock. J Nat Med 65:63–72
- Callaghan AO, Redmond HP. (2006). Treatment of sepsis: Current status of clinical immunotherapy. Surgeon 4:355–61
- Cruz DN, Antonelli M, Fumagalli R, et al. (2009). Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. JAMA 301:2445–52
- Dejager L, Pinheiro I, Dejonckheere E, Libert C. (2011). Cecal ligation and puncture: The gold standard model for polymicrobial sepsis? Trends Microbiol 19:198–208
- Dellinger RP, Levy MM, Carlet JM, et al. (2008). Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327
- Fioretto JR, Martin JG, Kurokawa CS, et al. (2008). Interleukin-6 and procalcitonin in children with sepsis and septic shock. Cytokine 43:160–4
- Fu JF, Cao HW, Wang N, et al. (2008). An anti-sepsis monomer, 2′,5′,6′,7-tetrahydroxyflavanonol (THF), identified from Scutellaria baicalensis Georgi neutralizes lipopolysaccharide in vitro and in vivo. Int Immunopharmacol 8:1652–7
- Gao XH, Xu XX, Pan R, et al. (2009). Saponin fraction from Astragalus membranaceus roots protects mice against polymicrobial sepsis induced by cecal ligation and puncture by inhibiting inflammation and upregulating protein C pathway. J Nat Med 63:421–9
- Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, et al. (2011). Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care 26:331.e1–331.e7
- Huttunen R, Aittoniemi J. (2011). New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect 63:407–19
- Jiang N, Xin WY, Wang T, et al. (2011). Protective effect of aescin from the seeds of Aesculus hippocastanum on liver injury induced by endotoxin in mice. Phytomedicine 18:1276–84
- Kolgazi M, Sener G, Çetinel S, et al. (2006). Resveratrol reduces renal and lung injury caused by sepsis in rats. J Surg Res 134:315–21
- Li H, Min YS, Park KC, Kim DS. (2012). Inhibition of melanogenesis by Xanthium strumarium L. Biosci Biotechnol Biochem 76:767–71
- Ma HY, Kou JP, Zhu DN, et al. (2006). Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-α levels, MDA content and enhancing macrophage phagocytosis. Int Immunopharmacol 6:1355–62
- Peng W, Ming QL, Han P, et al. (2014). Anti-allergic rhinitis effect of caffeoylxanthiazonoside isolated from fruits of Xanthium strumarium L. in rodent animals. Phytomedicine 21:824–9
- Qin LP, Han T, Li HL, et al. (2006). A new thiazinedione from Xanthium strumarium. Fitoterapia 77:245–6
- Qiu J. (2007). Traditional medicine: A culture in the balance. Nature 448:126–8
- Rittirsch D, Huber-Lang MS, Flierl MA, Award P. (2009). Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31–6
- Setoguchi D, Nakamura M, Yatsuki H, et al. (2011). Experimental examination of anti-inflammatory effects of a 5-HT3 receptor antagonist, tropisetron, and concomitant effects on autonomic nervous function in a rat sepsis model. Int Immunopharmacol 11:2073–8
- Wang LX, Jiang WW, Ding GF, et al. (2007). The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-α release. Int Immunopharmacol 7:646–55
- Wang N, XLiu N, Zheng XC, et al. (2013). Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model. Int Immunopharmacol 17:799–807
- Xue LM, Zhang QY, Han P, et al. (2014). Hepatotoxic constituents and toxicological mechanism of Xanthium strumarium L. fruits. J Ethnopharmacol 152:272–82
- Yang C, Wu K, Li SH, You Q. (2013). Protective effect of curcumin against cardiac dysfunction in sepsis rats. Pharm Biol 51:482–7
- Zheng XC, Yang D, Liu X, et al. (2010). Identification of a new anti-LPS agent, geniposide, from Gardenia jasminoides Ellis, and its ability of direct binding and neutralization of lipopolysaccharide in vitro and in vivo. Int Immunopharmacol 10:1209–19